MedPath

Mumps virus strain B level jeryl lynn live antigen

Generic Name
Mumps virus strain B level jeryl lynn live antigen
Brand Names
M-M-R II, Proquad
Drug Type
Biotech
Unique Ingredient Identifier
47QB6MX9KU

Overview

Mumps virus strain B level jeryl lynn live antigen is a live attenuated virus vaccine for subcutenous injection. It is an active immunization against mumps, which is a common childhood disease.

Background

Mumps virus strain B level jeryl lynn live antigen is a live attenuated virus vaccine for subcutenous injection. It is an active immunization against mumps, which is a common childhood disease.

Indication

Mumps virus vaccine is used to prevent mumps in combination with other virus vaccines, such as the rubella and measles virus vaccine.

Associated Conditions

  • Mumps

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Approved Products

Product Name
Manufacturer
Route
Strength
Approved
NDC Code
ORAL
30 [hp_X] in 1 mL
2025/05/15
83027-0071
The Wellness Center for Research and Education, Inc.
ORAL
15 [hp_X] in 1 mL
2025/05/28
50181-0042

EMA Approved Products

Medicine Name
EMA Number
Auth. Holder
Country
Drug Type
Status
Issued
Opinion
Revision
EMEA/H/C/000604
the netherlands
N/A
Authorised
2006/05/05
2006/02/23
34

NMPA Approved Products

Product Name
Approval No.
Manufacturer
Dosage Form
Trade Name
Strength
Type
Status
Date
Import

No NMPA products found

No NMPA products found for this drug

PPB Approved Products

Product Name
Registration Code
Company
Category
Sale Type
Reg. Date
HK-54831
merck sharp & dohme (asia) ltd
Part 1, Schedule 1 & Schedule 3 Poison & Antibiotic
POM
2006/10/05
© Copyright 2025. All Rights Reserved by MedPath